WebApr 7, 2024 · Last close prices updated as of Apr 06, 2024, 4:00 PM EST USD BATS BZX Real-Time Price Overview Key Ratios Trading Information Last Close 1.56 Sector … WebView the latest CytomX Therapeutics Inc. (CTMX) stock price, news, historical charts, analyst ratings and financial information from WSJ.
CTMX - CytomX Therapeutics, Inc. Stock Price and Quote
WebApr 13, 2024 · Stoke Therapeutics is trading at a lower price-to-earnings ratio than CytomX Therapeutics, indicating that it is currently the more affordable of the two stocks. ... CytomX Therapeutics has a beta of 0.65, meaning that its share price is 35% less volatile than the S&P 500. Comparatively, Stoke Therapeutics has a beta of 0.41, meaning that its ... WebApr 14, 2024 · Komo Plant Based Foods Inc. (OTCMKTS:KOMOF – Get Rating)’s share price traded down 4.1% during trading on Thursday .The stock traded as low as $0.09 and last traded at $0.13. 5,153 shares ... sims 4 all packs free 2023
FT Cboe Vest Nasdaq-100 Buffer ETF – March (BATS:QMAR) …
WebCytomX Therapeutics stock price target cut to $4 from $16 at Mizuho Jul. 7, 2024 at 7:08 a.m. ET by Tomi Kilgore CytomX Therapeutics downgraded to neutral from buy at … WebStock Symbol NASDAQ:CTMX Money Raised at IPO $80M IPO Share Price $12.00 IPO Date Oct 8, 2015 Stock chart by Investors Number of Lead Investors 3 Number of Investors 13 CytomX Therapeutics is funded by 13 investors. Wellington Management and Cormorant Asset Management are the most recent investors. WebWe're on it. CytomX is a different kind of clinical-stage biopharmaceutical company – intent on revolutionizing the way we treat cancer. Our distinctive Probody ® therapeutics are progressing through the clinic with the promise of unlocking the full potential of more potent, less toxic anti-cancer medications. Our ultimate goal is to bring a new generation of life … sims 4 all neighborhoods